利妥昔单抗联合他克莫司治疗成人复发性弥漫性足细胞病：一种治疗选择。 - Suppr

Rituximab with tacrolimus for relapsing diffuse podocytopathy in adulthood: A therapeutic option.

作者信息

Nimkar Abhishek, Yang Yihe, Jhaveri Kenar D

出版信息

Clin Nephrol. 2023 Aug;100(2):95-98. doi: 10.5414/CN111105.

DOI:10.5414/CN111105

PMID:37114493

Abstract

摘要

相似文献

Rituximab with tacrolimus for relapsing diffuse podocytopathy in adulthood: A therapeutic option.

Clin Nephrol. 2023 Aug;100(2):95-98. doi: 10.5414/CN111105.

Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain.

BioDrugs. 2017 Jun;31(3):239-249. doi: 10.1007/s40259-017-0221-x.

Short-term efficacy of rituximab versus tacrolimus in steroid-dependent nephrotic syndrome.

Pediatr Nephrol. 2012 Feb;27(2):235-41. doi: 10.1007/s00467-011-1997-4. Epub 2011 Sep 16.

Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.

Nephrology (Carlton). 2015 Jan;20(1):18-24. doi: 10.1111/nep.12351.

Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.

Pediatr Nephrol. 2016 Apr;31(4):589-94. doi: 10.1007/s00467-015-3245-9. Epub 2015 Nov 2.

Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study.

Turk J Med Sci. 2021 Aug 30;51(4):1781-1790. doi: 10.3906/sag-2012-297.

Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab.

Pediatr Nephrol. 2017 Nov;32(11):2071-2078. doi: 10.1007/s00467-017-3718-0. Epub 2017 Jun 29.

Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial.

Pediatr Nephrol. 2022 Dec;37(12):3117-3126. doi: 10.1007/s00467-022-05475-8. Epub 2022 Mar 14.

Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.

Transplant Proc. 2016 Nov;48(9):3092-3094. doi: 10.1016/j.transproceed.2016.07.001.

Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children.

Pediatr Nephrol. 2020 Jan;35(1):17-24. doi: 10.1007/s00467-018-4166-1. Epub 2018 Dec 18.

引用本文的文献

Evolutionary patterns and research frontiers in autophagy in podocytopathies: a bibliometric analysis.

Front Med (Lausanne). 2025 Jan 9;11:1445550. doi: 10.3389/fmed.2024.1445550. eCollection 2024.

Rituximab in Steroid-Dependent Podocytopathies.

Glomerular Dis. 2024 Jul 1;4(1):129-136. doi: 10.1159/000539922. eCollection 2024 Jan-Dec.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Rituximab with tacrolimus for relapsing diffuse podocytopathy in adulthood: A therapeutic option.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献